Yanyu Jiang

Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Acetoacetate-GPR43 axis epigenetically silences IL-6/CSF1 to restrict TAMs-driven metastatic lung cancer.

Acetoacetate-GPR43 axis epigenetically silences IL-6/CSF1 to restrict TAMs-driven metastatic lung cancer.

Journal: Journal of translational medicine

Published: March 24, 2026

SCFFBXW5-mediated degradation of AQP3 suppresses autophagic cell death through the PDPK1-AKT-MTOR axis in hepatocellular carcinoma cells.

SCFFBXW5-mediated degradation of AQP3 suppresses autophagic cell death through the PDPK1-AKT-MTOR axis in hepatocellular carcinoma cells.

Journal: Autophagy

Published: May 10, 2024

Ginsenosides: an immunomodulator for the treatment of colorectal cancer.

Ginsenosides: an immunomodulator for the treatment of colorectal cancer.

Journal: Frontiers in pharmacology

Published: March 29, 2024

Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy.

Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy.

Journal: Acta pharmaceutica Sinica. B

Published: January 16, 2023

Andrographolide Inhibits ER-Positive Breast Cancer Growth and Enhances Fulvestrant Efficacy via ROS-FOXM1-ER-α Axis.

Andrographolide Inhibits ER-Positive Breast Cancer Growth and Enhances Fulvestrant Efficacy via ROS-FOXM1-ER-α Axis.

Journal: Frontiers in oncology

Published: March 18, 2022

Five-day water-only fasting decreased metabolic-syndrome risk factors and increased anti-aging biomarkers without toxicity in a clinical trial of normal-weight individuals.

Five-day water-only fasting decreased metabolic-syndrome risk factors and increased anti-aging biomarkers without toxicity in a clinical trial of normal-weight individuals.

Journal: Clinical and translational medicine

Published: March 31, 2021

Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma.

Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma.

Journal: Cancer biology & medicine

Published: March 18, 2021

Neddylation Regulates Macrophages and Implications for Cancer Therapy.

Neddylation Regulates Macrophages and Implications for Cancer Therapy.

Journal: Frontiers in cell and developmental biology

Published: March 16, 2021

Camptothecin Inhibits Neddylation to Activate the Protective Autophagy Through NF-κB/AMPK/mTOR/ULK1 Axis in Human Esophageal Cancer Cells.

Camptothecin Inhibits Neddylation to Activate the Protective Autophagy Through NF-κB/AMPK/mTOR/ULK1 Axis in Human Esophageal Cancer Cells.

Journal: Frontiers in oncology

Published: February 23, 2021

Cullin3-TNFAIP1 E3 Ligase Controls Inflammatory Response in Hepatocellular Carcinoma Cells via Ubiquitination of RhoB.

Cullin3-TNFAIP1 E3 Ligase Controls Inflammatory Response in Hepatocellular Carcinoma Cells via Ubiquitination of RhoB.

Journal: Frontiers in cell and developmental biology

Published: October 14, 2020

NEDD8-conjugating enzyme UBC12 as a novel therapeutic target in esophageal squamous cell carcinoma.

NEDD8-conjugating enzyme UBC12 as a novel therapeutic target in esophageal squamous cell carcinoma.

Journal: Signal transduction and targeted therapy

Published: April 30, 2020

Neddylation inhibition activates the protective autophagy through NF-κB-catalase-ATF3 Axis in human esophageal cancer cells.

Neddylation inhibition activates the protective autophagy through NF-κB-catalase-ATF3 Axis in human esophageal cancer cells.

Journal: Cell communication and signaling : CCS

Published: December 12, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026